Detection of Dysglycemia, a Pre-Risk Factor for Cardiovascular Events, During World Diabetes Day 2018 and 2019 in An Urban Population Sample

Giuseppe Derosa^{1, 2,} , Pamela Maffioli¹, Catherine Klersy³, Virginia V. Ferretti³, Angela D’Angelo^{1, 2}, Sergio Di Matteo⁴, Giacomo M. Bruno⁵ and Giorgio L. Colombo⁵

¹Centre of Diabetes and Metabolic Diseases, Department of Internal Medicine and Therapeutics, University of Pavia and IRCCS Policlinico San Matteo Foundation, Pavia, Italy

²Laboratory of Molecular Medicine, University of Pavia, Pavia, Italy

³Clinical Epidemiology and Biometrics Unit, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

⁴S.A.V.E. Studi Analisi Valutazioni Economiche Research Centre, Milan, Italy

⁵Department of Drug Science, University of Pavia, Pavia, Italy

Cite this paper:
Giuseppe Derosa, Pamela Maffioli, Catherine Klersy, Virginia V. Ferretti, Angela D’Angelo, Sergio Di Matteo, Giacomo M. Bruno and Giorgio L. Colombo. Detection of Dysglycemia, a Pre-Risk Factor for Cardiovascular Events, During World Diabetes Day 2018 and 2019 in An Urban Population Sample. American Journal of Medical Sciences and Medicine. 2024; 12(1):16-20. doi: 10.12691/ajmsm-12-1-2

Abstract

It is well established that hypertension, hypercholesterolemia and type 2 diabetes (T2DM) are the main modifiable risk factors. The aim of this study was to identify the prevalence of dysglycemia in the general population screened during world diabetes day 2018 and 2019. In the context of the World Diabetes Day 2018 and 2019, promoted by the Department of Internal Medicine and Therapeutics, University of Pavia and IRCCS Policlinico San Matteo Foundation Hospital, Pavia, Italy, a total of 666 subjects aged ≥ 18 years, of either sex, agreed to participate in the screening for detection of pre-risk and risk cardiovascular factors. Exclusion criteria was prandial state. Participants included 274 men (41.14%) and 392 women (58.86%) with an average age of 55 (SD 13) years. There were 13 underweight subjects (1.95%), 317 subjects with normal weight (47.60%), 267 overweight subjects (40.09%) [body mass index (BMI), between 25.0 and 29.9 kg/m2] and 69 obese subjects (10.36%) (BMI ≥ 30 kg/m2). The prevalence of normo-glycemia was 61% (95% CI 57-65); of dysglycemia 28% (95% CI 24-31) and diabetes 11% (95% CI 9-14). In conclusions, in the context of the World Diabetes Day 2018 and 2019, we identified a prevalence of diabetes lower than the National reported value. Our main finding was the identification of a high prevalence of dysglycemic subjects, which should be taken into account in any primary or secondary prevention strategies.

Keywords:
Dysglycemia dyslipidemia pre-hypertension hypertension pre-risk

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Derosa G, Maffioli P. Dysglycaemia, diagnosis and treatment. Nutrafoods 2017; 16: 137-139.
[2]	https://www.istat.it/en/files/2017/07/Report_Diabetes_En_def.pdf?title=Diabetes+in+Italy+-+24+Jul+2017+-+Full+text.pdf.
[3]	American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41: S13-27.
[4]	Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world--a growing challenge. N Engl J Med 2007; 356(3): 213-215.
[5]	Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006; 29(5): 1130-1139.
[6]	Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28(12): 1462-1536.
[7]	https:// www.biosys.it/pdf/bsi_lux.pdf.
[8]	Rapi S, Bazzini C, Tozzetti C, et al. Point-of-care testing of cholesterol and triglycerides for epidemiologic studies: evaluation of the multicare-in system. Transl Res 2009; 153(2): 71-76.
[9]	Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
[10]	Mortensen LS, Hartvigsen ML, Brader LJ, et al. Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein. Am J Clin Nutr 2009; 90: 41-48.
[11]	Lebovitz HE, Ludvik B, Yaniv I, et al. Fasting plasma triglycerides predict the glycaemia response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm. Diabetic Med 2013; 30: 687-693.
[12]	Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J 2015; 39: 353-362.